Skip to main content
. 2021 Apr 12;17:1021–1034. doi: 10.2147/NDT.S290104

Table 1.

Characteristics of the Study Population with and without Benzodiazepine and Z-Drug Use in 2018

Variable Total Benzodiazepine User Benzodiazepine Non-User P-value Z-Drug User Z-Drug Non User P-value Benzodia-Zepine and/or Z-Drug User No Drug Use P-value
N(%) N(%) N(%) N(%) N(%) N(%) N(%)
Total 844ʹ692 73ʹ719 (8.7%) 770ʹ973 (91.3%) 31ʹ652 (3.7%) 813ʹ040 (96.3%) 95ʹ179 (11.3%) 749ʹ513 (88.7%)
Gender <0.001' <0.001' <0.001'
 Female 443ʹ707 (52.5%) 48ʹ267 (65.5%) 395ʹ440 (51.3%) 21ʹ099 (66.7%) 422ʹ608 (52%) 62ʹ435 (65.6%) 381ʹ272 (50.9%)
 Male 400ʹ985 (47.5%) 25ʹ452 (34.5%) 375ʹ533 (48.7%) 10ʹ553 (33.3%) 390ʹ432 (48.0%) 32ʹ744 (34.4%) 368ʹ241 (49.1%)
Mean age (SD) 51.5 (19.58) 63.0 (18.42) 50.3 (19.33) <0.001'' 65.5 (17.23) 50.9 (19.47) <0.001'' 63.7 (18.17) 49.9 (19.20) <0.001''
Age group (in years) <0.001''' <0.001''' <0.001'''
 18–24 82ʹ328 (9.7%) 2ʹ173 (2.9%) 80ʹ155 (10.4%) 503 (1.6%) 81ʹ825 (10.1%) 2ʹ496 (2.6%) 79ʹ832 (10.7%)
 25–34 116ʹ981 (13.8%) 4ʹ205 (5.7%) 112ʹ776 (14.6%) 1ʹ311 (4.1%) 115ʹ670 (14.2%) 5ʹ019 (5.3%) 111ʹ962 (14.9%)
 35–44 131ʹ071 (15.5%) 6ʹ697 (9.1%) 124ʹ374 (16.1%) 2ʹ341 (7.4%) 128ʹ730 (15.8%) 8ʹ116 (8.5%) 122ʹ955 (16.4%)
 45–54 142ʹ710 (16.9%) 10ʹ188 (13.8%) 132ʹ522 (17.2%) 4ʹ090 (12.9%) 138ʹ620 (17.0%) 12ʹ806 (13.5%) 129ʹ904 (17.3%)
 55–64 132ʹ916 (15.7%) 12ʹ213 (16.6%) 120ʹ703 (15.7%) 5ʹ389 (17.0%) 127ʹ527 (15.7%) 15ʹ781 (16.6%) 117ʹ135 (15.6%)
 65–74 116ʹ274 (13.8%) 15ʹ082 (20.5%) 101ʹ192 (13.1%) 6ʹ768 (21.4%) 109ʹ506 (13.5%) 19ʹ737 (20.7%) 96ʹ537 (12.9%)
 75–84 84ʹ159 (10.0%) 14ʹ952 (20.3%) 69ʹ207 (9.0%) 7ʹ281 (23.0%) 76ʹ878 (9.5%) 20ʹ094 (21.1%) 64ʹ065 (8.5%)
 ≥85 38ʹ253 (4.5%) 8ʹ209 (11.1%) 30ʹ044 (3.9%) 3ʹ969 (12.5%) 34ʹ284 (4.2%) 11ʹ130 (11.7%) 27ʹ123 (3.6%)
Language region <0.001''' <0.001''' <0.001'''
 German (incl. raetorom.) 632ʹ294 (74.9%) 46ʹ011 (62.4%) 586ʹ283 (76.0%) 21ʹ140 (66.8%) 611ʹ154 (75.2%) 61ʹ424 (64.5%) 570ʹ870 (76.2%)
 French 158ʹ792 (18.8%) 18ʹ893 (25.6%) 139ʹ899 (18.1%) 8ʹ315 (26.3%) 150ʹ477 (18.5%) 23ʹ669 (24.9%) 135ʹ123 (18.0%)
 Italian 53ʹ606 (6.3%) 8ʹ815 (12.0%) 44ʹ791 (5.8%) 2ʹ197 (6.9%) 51ʹ409 (6.3%) 10ʹ086 (10.6%) 43ʹ520 (5.8%)
Region of residence <0.001' <0.001' <0.001'
 Urban 731ʹ210 (86.6%) 65ʹ180 (88.4%) 666ʹ030 (86.4%) 27ʹ776 (87.8%) 703ʹ434 (86.5%) 83ʹ899 (88.1%) 647ʹ311 (86.4%)
 Rural 113ʹ482 (13.4%) 8ʹ539 (11.6) 104ʹ943 (13.6%) 3ʹ876 (12.2%) 109ʹ606 (13.5%) 11ʹ280 (11.9%) 102ʹ202 (13.6%)
Healthcare plan
Managed care model <0.001' <0.001' <0.001'
 Yes 574ʹ256 (68.0%) 41ʹ632 (56.5%) 532ʹ624 (69.1%) 17ʹ933 (56.7%) 556ʹ323 (68.4%) 54ʹ120 (56.9%) 520ʹ136 (69.4%)
 No 270ʹ436 (32%) 32ʹ087 (43.5%) 238ʹ349 (30.9%) 13ʹ719 (43.3%) 256ʹ717 (31.6%) 41ʹ059 (43.1%) 229ʹ377 (30.6%)
Deductible <0.001' <0.001' <0.001'
 Low 547ʹ281 (64.8%) 65ʹ203 (88.4%) 482ʹ078 (62.5%) 28ʹ252 (89.3%) 519ʹ029 (63.8%) 84ʹ191 (88.5%) 463ʹ090 (61.8%)
 High 297ʹ411 (35.2%) 8ʹ516 (11.6%) 288ʹ895 (37.5%) 3ʹ400 (10.7%) 294ʹ011 (36.2%) 10ʹ988 (11.5%) 286ʹ423 (38.2%)
Number of comorbidities <0.001''' <0.001''' <0.001'''
 0 418ʹ697 (49.6%) 6ʹ025 (8.2%) 412ʹ672 (53.5%) 2ʹ206 (7.0%) 416ʹ491 (51.2%) 7ʹ974 (8.4%) 410ʹ723 (54.8%)
 1 154ʹ886 (18.3%) 11ʹ021 (15.0%) 143ʹ865 (18.7%) 4ʹ212 (13.3%) 150ʹ674 (18.5%) 14ʹ253 (15.0%) 140ʹ633 (18.8%)
 2 104ʹ348 (12.4%) 13ʹ451 (18.2%) 90ʹ897 (11.8%) 5ʹ302 (16.8%) 99ʹ046 (12.2%) 17ʹ183 (18.1%) 87ʹ165 (11.6%)
 ≥3 166ʹ761 (19.7%) 43ʹ222 (58.6%) 123ʹ539 (16.0%) 19ʹ932 (63.0%) 146ʹ829 (18.1%) 55ʹ769 (58.6%) 110ʹ992 (14.8%)

Notes: 'Fisher exact test; ''Kruskal-Wallis test; '''Chi-Square test.